GRAIL Reports Topline Results from NHS-Galleri Trial of Multi-Cancer Early Detection Test
Results from the NHS-Galleri trial show that annual multi-cancer screening with the Galleri test reduced Stage IV diagnoses and significantly increased early cancer detection across England’s NHS population.
NHS England | 20/02/2026 | By News Bureau | 178
Alvotech Announces European Launch of Golimumab Biosimilar via Advanz Pharma
Alvotech has announced the European launch of AVT05, the first biosimilar to Simponi (golimumab), through its partner Advanz Pharma, following a tender award from NHS England in the UK to support market introduction.
NHS England | 22/12/2025 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy